The landscape of U.S. immigration law is constantly shifting; don’t let this uncertainty impact your business.
It is crucial for employers to stay informed about the ever-evolving landscape of U.S. immigration laws and policies. This webinar will provide a comprehensive overview of the latest developments in immigration law, discuss the Trump administration’s executive orders and their impact on immigration and your business, review critical compliance requirements, and share proactive strategies for employers.
In this session, you will learn:
- A detailed review of current immigration enforcement activity impacting employers
- Analysis of recent policy changes and potential future developments
- Why you may want to review your “public space vs. private space” policies
- Strategies for preparing for ICE audits and worksite enforcement actions
- What types of enforcement actions to expect
- Best practices for mitigating legal risks
Join us and gain practical insights to ensure your business remains compliant and your workforce secure.
For a PDF of the presentation, please click here.
Webinar Recording
People
Related Insights
Watch On-Demand
Upcoming
Events
Get Anytime Access to Continuing Legal Education and Business Programming
Our new LearningLab: On-Demand Hub offers a growing library of continuing legal education (CLE) and business-focused legal insights you can now access anytime, anywhere.
December 7, 9, and 11
Upcoming
Events
Milwaukee CLE Week 2026
Foley has a rich history of supporting our clients with in-person CLE opportunities. We are excited to invite you to Foley’s Annual Milwaukee CLE Week, a three day, in-person event held at Foley’s Milwaukee office, designed to deliver timely insights on key business, industry, and ethics topics.
November 17, 2026
Foley Viewpoints
Entering the U.S. Market? Corporate Compliance Is Your First Priority.
Led by the U.S. Department of Justice (DOJ) and the U.S. Department of Health & Human Services’ Office of Inspector General (OIG), enforcement efforts have historically been active for health care companies of all types and medical device companies have not been spared.